ANGO AngioDynamics, Inc. - Common Stock
NASDAQ · Health Care · Wyświetl na SEC EDGAR ↗ 10-K/10-Q Paź 8, 2026
$12,13
· % zakresu 52 tyg.
· powyżej minimum
· do maksimum
$9,3952tyg. minimum
$16,2952tyg. maksimum
Kapitalizacja Rynkowa (MRQ)
$515M
P/E (TTM)
-15.4
EPS (TTM)
$-0.79
Przychody (TTM)
$325M
Twoje odznaki
Zakres 52 tyg.
$9–$16
Ocena Analityków
BUY
Cena Docelowa
$20
P/E
-15.4
ROE
-19.2%
Marża Zysku Netto
-10.1%
Twój pasek odznak jest pusty — przypnij metrykę w dowolnym miejscu na tej stronie.
ANGO Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$12.13
Kapitalizacja Rynkowa (MRQ)
$515M
P/E (TTM)
-15.4
EPS (TTM)
$-0.79
Przychody (TTM)
$325M
ROE (TTM)
-19.2%
Zakres 52 tyg.
$9–$16
ANGO Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
zakres
kreski
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody$320M2017-05-31 → 2026-05-31
EPS$-0.882017-05-31 → 2026-05-31
Wolny przepływ pieniężny·2017-05-31 → 2025-05-31
Marża netto-10.1%2017-05-31 → 2025-05-31
Wycena i wskaźniki
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | ANGO | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | -15.4średnia z 5 lat ≈-12.5 | ≈-12.5 | · | · | |
| P/S (TTM) | 1.6średnia z 5 lat ≈1.5 | ≈1.5 | 5.0 | Niedowartościowany | |
| P/B (MRQ) | 3.1średnia z 5 lat ≈1.6 | ≈1.6 | 3.7 | Zawyżona wycena | |
| Cena / FCF (TTM) | 356.4średnia z 5 lat ≈-51.1 | ≈-51.1 | · | · | |
| Cena / Przepływy pieniężne (TTM) | 140.1średnia z 5 lat ≈1161.7 | ≈1161.7 | 20.9 | Zawyżona wycena | |
| Cena / Wartość księgowa materialna (MRQ) | 5.0średnia z 5 lat ≈4.9 | ≈4.9 | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | ANGO | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża brutto (TTM) | 55.7%średnia z 5 lat ≈52.2% | ≈52.2% | 77.2% | Słaby | |
| Marża Operacyjna (TTM) | -11.2%średnia z 5 lat ≈-25.3% | ≈-25.3% | -16.4% | Najwyższa półka | |
| Marża przed opodatkowaniem (TTM) | -10.1%średnia z 5 lat ≈-25.1% | ≈-25.1% | -15.5% | Najwyższa półka | |
| Marża Zysku Netto (TTM) | -10.1%średnia z 5 lat ≈-24.0% | ≈-24.0% | -19.1% | Najwyższa półka | |
| ROA (TTM) | -13.0%średnia z 5 lat ≈-17.3% | ≈-17.3% | -21.1% | Najwyższa półka | |
| ROE (TTM) | -19.2%średnia z 5 lat ≈-31.3% | ≈-31.3% | -43.8% | Najwyższa półka |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | ANGO | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Wskaźnik bieżący (MRQ) | 2.4średnia z 5 lat ≈2.1 | ≈2.1 | 4.9 | Niska płynność |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | ANGO | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | 9.5%średnia z 5 lat ≈2.2% | ≈2.2% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | -1.9%średnia z 5 lat ≈1.4% | ≈1.4% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | 1.9% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | ANGO | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue / Employee (Przychody / pracownika) | ≈$506.6K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Wskaźnik przekroczeń
100.0%
Średnie zaskoczenie
73.4%
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 31 marca 2027 | Paź 1, 2026 | $-0.04 | $-0.12 | 65.4% |
| 30 września 2026 | $-0.04 | $-0.12 | 65.4% | |
| 30 czerwca 2026 | $-0.07 | $-0.09 | 23.7% | |
| 31 marca 2026 | $0.02 | $-0.11 | 117.8% | |
| 31 grudnia 2025 | $0.00 | $-0.10 | 100.0% | |
| 30 września 2025 | $-0.10 | $-0.12 | 16.6% | |
| 30 czerwca 2025 | $-0.03 | $-0.12 | 75.5% | |
| 31 marca 2025 | $0.03 | $-0.13 | 122.6% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $320M | $292M | $304M | $339M | $316M | $291M | $264M | $271M | $262M | $270M | $354M | $357M | |
| Cost of Revenue | $145M | $135M | $149M | $165M | $150M | $134M | $114M | $115M | $118M | $126M | $180M | $181M | |
| Gross Profit | $175M | $158M | $155M | $174M | $166M | $157M | $150M | $156M | $144M | $144M | $174M | $176M | |
| R&D Expense | $29M | $26M | $32M | $30M | $31M | $36M | $30M | $28M | $24M | $24M | $25M | $27M | |
| SG&A Expense | $44M | $42M | $41M | $40M | $38M | $36M | $38M | $35M | $31M | $31M | $31M | $30M | |
| Operating Expenses | $215M | $198M | $402M | $225M | $194M | $192M | $317M | $165M | $158M | $155M | $173M | $179M | |
| Operating Income | $-40M | $-40M | $-192M | $-51M | $-28M | $-35M | $-167M | $-9M | $-14M | $-11M | $1M | $-3M | |
| Interest Expense | · | · | $-2M | $3M | $688.0K | $861.0K | $907.0K | $5M | $3M | $3M | $3M | $3M | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | $11.0K | $4.0K | |
| Other Non-op | $4M | $5M | $-817.0K | $-554.0K | $-790.0K | $92.0K | $-130.0K | $-207.0K | $-3M | $-3M | $-4M | $-5M | |
| Pretax Income | $-36M | $-34M | $-192M | $-54M | $-30M | $-36M | $-168M | $-15M | $-17M | $-14M | $-3M | $-8M | |
| Income Tax | $442.0K | $-39.0K | $-7M | $-2M | $-3M | $-5M | $-1M | $-4M | $-11M | $-7M | $40M | $-5M | |
| Net Income | $-37M | $-34M | $-184M | $-52M | $-27M | $-32M | $-167M | $61M | $16M | $5M | $-44M | $-3M | |
| EPS (Basic) | $-0.88 | $-0.83 | $-4.59 | $-1.33 | $-0.68 | $-0.82 | $-4.39 | $1.64 | $0.44 | $0.14 | $-1.21 | $-0.09 | |
| EPS (Diluted) | $-0.88 | $-0.83 | $-4.59 | $-1.33 | $-0.68 | $-0.82 | $-4.39 | $1.64 | $0.44 | $0.14 | $-1.21 | $-0.09 | |
| Shares (Basic) | 41,526,000 | 40,853,000 | 40,181,000 | 39,480,000 | 39,009,000 | 38,342,000 | 37,961,000 | 37,485,000 | 37,075,000 | 36,617,000 | 36,161,000 | 35,683,139 | |
| Shares (Diluted) | 41,526,000 | 40,853,000 | 40,181,000 | 39,480,000 | 39,009,000 | 38,342,000 | 37,961,000 | 37,485,000 | 37,075,000 | 36,617,000 | 36,161,000 | 35,683,139 | |
| EBITDA | · | $-40M | $-192M | $-51M | $-28M | $-35M | $-167M | $-9M | $11M | $13M | · | $-994.0K |
Bilans
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $54M | $56M | $76M | $45M | $29M | $48M | $54M | $228M | $74M | $48M | $32M | $18M | |
| Receivables | $48M | $43M | $44M | $53M | $52M | $35M | $31M | $44M | $39M | $45M | $53M | $58M | |
| Inventory | $52M | $62M | $61M | $55M | $51M | $49M | $60M | $40M | $39M | $55M | $55M | $67M | |
| Prepaid Expense | $9M | $8M | $13M | $5M | $11M | $9M | $7M | $4M | $4M | $6M | $3M | $4M | |
| Current Assets | $163M | $168M | $193M | $164M | $143M | $141M | $153M | $315M | $168M | $154M | $146M | $151M | |
| PP&E (Net) | $27M | $32M | $36M | $44M | $45M | $37M | $28M | $24M | $26M | $45M | $48M | $54M | |
| PP&E (Gross) | · | · | $108M | $103M | $96M | $82M | $69M | $65M | $64M | $93M | $90M | $89M | |
| Accum. Depreciation | · | · | $70M | $59M | $51M | $46M | $41M | $42M | $39M | $50M | $44M | $36M | |
| Goodwill | · | · | $0 | $159M | $201M | $201M | $201M | $348M | $286M | $361M | $361M | $361M | |
| Intangibles | $67M | $69M | $77M | $111M | $152M | $169M | $197M | $145M | $113M | $146M | $167M | $182M | |
| Other Non-current Assets | $9M | $10M | $11M | $11M | $11M | $13M | $15M | $4M | $3M | $2M | $4M | $5M | |
| Total Assets | $267M | $280M | $318M | $533M | $553M | $561M | $594M | $836M | $705M | $708M | $726M | $773M | |
| Accounts Payable | $32M | $33M | $38M | $40M | $28M | $20M | $19M | $23M | $16M | $18M | $16M | $23M | |
| Accrued Liabilities | $39M | $36M | $41M | $27M | $35M | $35M | $29M | $38M | $34M | $39M | $22M | $18M | |
| Current Liabilities | $75M | $76M | $91M | $84M | $74M | $58M | $51M | $73M | $57M | $72M | $67M | $61M | |
| Capital Leases | $4M | $2M | $4M | $3M | $5M | $7M | $8M | · | · | · | · | · | |
| Other Non-current Liabilities | $16M | $17M | $16M | $3M | $5M | $9M | $9M | $521.0K | $621.0K | $850.0K | $908.0K | $0 | |
| Total Liabilities | $96M | $97M | $112M | $154M | $128M | $122M | $139M | $222M | $163M | $193M | $219M | $228M | |
| Long-term Debt | · | · | $0 | $50M | $25M | · | · | $132M | $92M | $96M | · | · | |
| Total Debt | · | · | · | · | · | · | $0 | $132M | $92M | $96M | · | $9M | |
| Common Stock | $387.0K | $385.0K | $385.0K | $382.0K | $380.0K | $377.0K | $374.0K | $372.0K | $370.0K | $367.0K | $363.0K | $360.0K | |
| Retained Earnings | $-466M | $-429M | $-395M | $-211M | $-158M | $-132M | $-100M | $66M | $5M | $-11M | $-16M | $28M | |
| Treasury Stock | $7M | $7M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $2M | $2M | |
| AOCI | $8M | $-2M | $-4M | $-5M | $1M | $3M | $-1M | $-1M | $-952.0K | $-1M | $-791.0K | $-833.0K | |
| Stockholders' Equity | $171M | $183M | $206M | $378M | $424M | $439M | $455M | $615M | $543M | $515M | $507M | $545M | |
| Liabilities + Equity | $267M | $280M | $318M | $533M | $553M | $561M | $594M | $836M | $705M | $708M | $726M | $773M | |
| Shares Outstanding | 41,700,419 | 40,994,030 | 40,801,597 | 39,981,422 | 39,541,173 | 38,920,951 | 38,448,536 | 37,984,382 | 37,224,493 | 36,840,091 | 36,278,098 | 35,901,420 |
Przepływy pieniężne
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $23M | $26M | $28M | $31M | $29M | $26M | $24M | $26M | $23M | $25M | $28M | $30M | |
| Stock-based Comp | $14M | $10M | $11M | $11M | $11M | $9M | $8M | $9M | $8M | $6M | $3M | $6M | |
| Deferred Tax | $143.0K | $-988.0K | $-8M | $-2M | $-4M | $-5M | $-2M | $-4M | $-11M | $-8M | $40M | $-5M | |
| Amort. of Intangibles | $11M | $10M | $13M | $19M | $19M | $18M | $18M | $17M | $14M | $15M | $18M | $18M | |
| Restructuring | $13M | $14M | · | · | · | · | $26.0K | $288.0K | $5M | $1M | $0 | · | |
| Operating Cash Flow | $3M | $-10M | $-28M | $78.0K | $-7M | $24M | $-15M | $37M | $41M | $56M | $45M | $26M | |
| CapEx | $3M | $4M | $3M | $4M | $4M | $5M | $7M | $3M | $2M | $3M | $2M | $11M | |
| Investing Cash Flow | $-6M | $-10M | $124M | $-10M | $-19M | $-14M | $-63M | $83M | $-4M | $-3M | $-8M | $-13M | |
| Debt Issued | · | · | · | · | · | · | · | $0 | $0 | $116M | $0 | $15M | |
| Net Debt Issued | · | $0 | $-50M | $-45M | $0 | $-20M | $-132M | $-15M | $-5M | $-24M | · | $-5M | |
| Stock Repurchased | $0 | $2M | $0 | $0 | · | · | · | $0 | $0 | $14M | $0 | $0 | |
| Net Stock Activity | · | $-2M | · | · | · | · | · | $0 | $0 | $-14M | · | · | |
| Financing Cash Flow | $564.0K | $-255.0K | $-64M | $25M | $8M | $-17M | $-95M | $34M | $-12M | $-38M | $-24M | $-10M | |
| Net Change in Cash | $-2M | $-20M | $31M | $16M | $-19M | $-6M | $-173M | $154M | $27M | $15M | $14M | $2M | |
| Taxes Paid | $405.0K | $800.0K | $455.0K | $342.0K | $329.0K | $313.0K | $682.0K | $426.0K | $36.0K | $-102.0K | $332.0K | · | |
| Free Cash Flow | · | $-15M | $-31M | $-4M | $-11M | $19M | $-22M | $34M | $39M | $53M | · | $14M | |
| Levered FCF | · | · | $-29M | $-6M | $-12M | $18M | $-23M | $30M | $32M | $51M | · | $13M |
Rentowność
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 53.9% | 50.9% | 51.4% | 52.4% | 53.9% | 56.9% | 57.6% | 51.4% | 50.4% | · | 49.5% | |
| Operating Margin | · | -13.7% | -63.3% | -15.1% | -9.0% | -12.1% | -63.3% | -3.5% | 3.1% | 3.7% | · | -0.28% | |
| Net Margin | · | -11.6% | -60.7% | -15.5% | -8.4% | -10.8% | -63.1% | 22.7% | 4.7% | 1.4% | · | -0.92% | |
| Pretax Margin | · | -11.6% | -63.1% | -16.1% | -9.5% | -12.4% | -63.6% | -5.4% | 2.2% | 2.8% | · | -2.2% | |
| EBITDA Margin | · | -13.7% | -63.3% | -15.1% | -9.0% | -12.1% | -63.3% | -3.5% | 3.1% | 3.7% | · | -0.28% | |
| ROA | · | -11.4% | -43.4% | -9.7% | -4.8% | -5.5% | -23.3% | 8.0% | 2.3% | 0.70% | · | -0.42% | |
| ROE | · | -18.4% | -86.9% | -13.5% | -6.2% | -7.0% | -31.3% | 10.5% | 3.1% | 0.98% | · | -0.60% | |
| ROIC | · | -21.8% | -90.0% | -13.0% | -5.9% | -7.0% | -36.4% | -0.95% | 3.6% | 1.1% | · | -0.07% |
Płynność i wypłacalność
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 2.2 | 2.1 | 2.0 | 1.9 | 2.4 | 3.0 | 4.3 | 2.9 | 2.2 | · | 2.5 | |
| Quick Ratio | · | 1.3 | 1.3 | 1.2 | 1.1 | 1.5 | 1.7 | 3.7 | 2.0 | 1.3 | · | 1.3 | |
| Debt / Equity | · | · | · | · | · | · | 0.0 | 0.2 | 0.2 | 0.2 | · | 0.0 | |
| LT Debt / Equity | · | · | · | · | · | · | · | 0.2 | 0.2 | 0.2 | · | · | |
| Interest Coverage | · | · | 119.2 | -18.9 | -41.4 | -41.0 | -184.2 | -1.8 | 3.4 | 4.6 | · | -0.3 |
Efektywność
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 1.0 | 0.7 | 0.6 | 0.6 | 0.5 | 0.4 | 0.4 | 0.5 | 0.5 | · | 0.5 | |
| Inventory Turnover | · | 2.2 | 2.6 | 3.1 | 3.0 | 2.5 | 2.3 | 2.9 | 3.2 | 3.2 | · | 2.6 | |
| Receivables Turnover | · | 6.8 | 6.3 | 6.4 | 7.2 | 8.7 | 7.1 | 6.5 | 8.2 | 7.2 | · | 5.9 |
Na akcję
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $4.46 | $5.08 | $9.55 | $10.84 | $11.40 | $11.95 | $16.35 | $14.58 | $13.98 | · | $15.12 | |
| Revenue / Share | · | $7.16 | $7.56 | $8.58 | $8.11 | $7.59 | $6.96 | $7.22 | $9.17 | $9.46 | · | $10.00 | |
| Cash Flow / Share | · | $-0.25 | $-0.70 | $0.00 | $-0.18 | $0.63 | $-0.38 | $1.00 | $1.10 | $1.51 | · | $0.74 | |
| Cash / Share | · | $1.36 | $1.88 | $1.13 | $0.74 | $1.25 | $1.43 | $6.05 | $1.99 | $1.29 | · | $0.51 | |
| EPS (TTM) | $-0.88 | $-0.83 | $-4.59 | $-1.33 | $-0.68 | $-0.82 | $-4.39 | $1.64 | $0.44 | $0.14 | $-1.21 | $-0.09 |
Stopy Wzrostu
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 9.5% | -3.8% | -10.3% | 7.1% | 8.7% | 10.2% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -1.9% | -2.6% | 1.5% | 8.6% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 1.9% | 2.1% | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $320M | $292M | $304M | $339M | $316M | $291M | $264M | $271M | $262M | $270M | $354M | $357M | |
| Net Income TTM | $-37M | $-34M | $-184M | $-52M | $-27M | $-32M | $-167M | $61M | $16M | $5M | $-44M | $-3M | |
| Market Cap | · | $418M | $255M | $375M | $769M | $891M | $389M | $707M | $783M | $556M | · | $579M | |
| Enterprise Value | · | · | · | · | · | · | $334M | $611M | $800M | $604M | · | $569M | |
| P/E | -13.0 | -12.3 | -1.4 | -7.1 | -28.9 | -28.2 | -2.3 | 11.5 | 47.8 | 107.7 | -9.9 | -178.3 | |
| P/S | · | 1.4 | 0.8 | 1.1 | 2.4 | 3.1 | 1.5 | 2.6 | 3.0 | 2.1 | · | 1.6 | |
| P/B | · | 2.3 | 1.2 | 1.0 | 1.8 | 2.0 | 0.9 | 1.1 | 1.4 | 1.1 | · | 1.1 | |
| P / Tangible Book | 4.6 | 3.7 | 2.0 | 3.5 | 10.8 | 12.9 | 6.8 | · | · | · | · | · | |
| P / Cash Flow | · | -41.3 | -9.1 | 4804.2 | -106.9 | 37.0 | -26.7 | 18.9 | 19.0 | 10.0 | · | 22.0 | |
| P / FCF | · | -28.7 | -8.3 | -100.4 | -66.9 | 47.1 | -17.8 | 20.6 | 20.1 | 10.5 | · | 40.4 | |
| EV / EBITDA | · | · | · | · | · | · | -2.0 | -65.0 | 75.8 | 46.6 | · | -572.3 | |
| EV / FCF | · | · | · | · | · | · | -15.3 | 17.8 | 20.6 | 11.5 | · | 39.8 | |
| EV / Revenue | · | · | · | · | · | · | 1.3 | 2.3 | 3.1 | 2.2 | · | 1.6 | |
| Earnings Yield | -7.7% | -8.1% | -72.7% | -14.1% | -3.5% | -3.5% | -43.0% | 8.7% | 2.1% | 0.93% | -10.1% | -0.56% |
Rachunek zysków i strat
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $81M | $87M | $78M | $79M | $76M | $80M | $72M | $73M | $67M | $71M | $75M | $79M | $79M | $91M | $81M | $85M | |
| Cost of Revenue | $33M | $40M | $37M | $35M | $34M | $38M | $33M | $33M | $31M | $32M | $39M | $39M | $39M | $45M | $40M | $40M | |
| Gross Profit | $48M | $47M | $41M | $45M | $42M | $42M | $39M | $40M | $37M | $39M | $36M | $40M | $40M | $46M | $41M | $45M | |
| R&D Expense | $8M | $8M | $7M | $8M | $6M | $7M | $7M | $6M | $6M | $7M | $8M | $9M | $8M | $8M | $7M | $7M | |
| SG&A Expense | $12M | $10M | $11M | $10M | $13M | $10M | $10M | $10M | $11M | $10M | $11M | $9M | $11M | $10M | $9M | $11M | |
| Operating Expenses | $55M | $57M | $54M | $51M | $53M | $48M | $49M | $51M | $50M | $53M | $242M | $53M | $53M | $67M | $49M | $53M | |
| Operating Income | $-7M | $-10M | $-13M | $-6M | $-11M | $-6M | $-10M | $-11M | $-13M | $-14M | $-200M | $-13M | $35M | $-21M | $-9M | $-8M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | $-394.0K | $-534.0K | $-119.0K | · | $736.0K | $684.0K | |
| Other Non-op | $94.0K | $-735.0K | $5M | $-128.0K | $-178.0K | $-325.0K | $5M | $12.0K | $-173.0K | $-259.0K | $-238.0K | $-32.0K | $-288.0K | $-127.0K | $0 | $-252.0K | |
| Pretax Income | $-7M | $-11M | $-8M | $-6M | $-11M | $-6M | $-4M | $-11M | $-13M | $-14M | $-200M | $-13M | $35M | $-22M | $-10M | $-9M | |
| Income Tax | $-199.0K | $370.0K | $12.0K | $-5.0K | $65.0K | $-60.0K | $-2.0K | $-110.0K | $133.0K | $-692.0K | $-12M | $16M | $-11M | $-398.0K | $-179.0K | $-565.0K | |
| Net Income | $-7M | $-11M | $-8M | $-6M | $-11M | $-6M | $-4M | $-11M | $-13M | $-13M | $-188M | $-29M | $46M | $-21M | $-9M | $-8M | |
| EPS (Basic) | $-0.17 | $-0.28 | $-0.19 | $-0.15 | $-0.26 | $-0.15 | $-0.11 | $-0.26 | $-0.31 | $-0.35 | $-4.67 | $-0.72 | $1.15 | $-0.55 | $-0.24 | $-0.21 | |
| EPS (Diluted) | $-0.17 | $-0.28 | $-0.19 | $-0.15 | $-0.26 | $-0.15 | $-0.11 | $-0.26 | $-0.31 | $-0.35 | $-4.67 | $-0.72 | $1.15 | $-0.55 | $-0.24 | $-0.21 | |
| Shares (Basic) | 42,022,000 | · | 41,596,000 | 41,542,000 | 41,174,000 | · | 40,853,000 | 40,922,000 | 40,653,000 | · | 40,234,000 | 40,219,000 | 39,842,000 | · | 39,509,000 | 39,490,000 | |
| Shares (Diluted) | 42,022,000 | · | 41,596,000 | 41,542,000 | 41,174,000 | · | 40,853,000 | 40,922,000 | 40,653,000 | · | 40,234,000 | 40,219,000 | 39,968,000 | · | 39,509,000 | 39,490,000 | |
| EBITDA | $-7M | · | $-13M | $-6M | $-11M | · | $-10M | $-11M | $-13M | · | $-200M | $-13M | $35M | · | $-9M | $-8M |
Bilans
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $34M | $54M | $38M | $42M | $39M | $56M | $45M | $54M | $55M | $76M | $78M | $61M | $58M | · | $30M | $30M | |
| Receivables | $45M | $48M | $46M | $44M | $43M | $43M | $43M | $43M | $40M | $44M | $49M | $52M | $50M | · | $51M | $53M | |
| Inventory | $55M | $52M | $59M | $66M | $62M | $62M | $63M | $66M | $65M | $61M | $58M | $64M | $60M | · | $64M | $63M | |
| Prepaid Expense | $9M | $9M | $14M | $10M | $13M | $8M | $15M | $12M | $13M | $13M | $11M | $9M | $8M | · | $8M | $13M | |
| Current Assets | $143M | $163M | $156M | $161M | $157M | $168M | $172M | $175M | $173M | $193M | $197M | $185M | $175M | · | $153M | $159M | |
| PP&E (Net) | $28M | $27M | $29M | $31M | $31M | $32M | $33M | $33M | $34M | $36M | $37M | $43M | $43M | · | $46M | $46M | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | $0 | $159M | $159M | · | $200M | $201M | |
| Intangibles | $62M | $67M | $65M | $67M | $68M | $69M | $71M | $73M | $76M | $77M | $82M | $104M | $107M | · | $134M | $142M | |
| Other Non-current Assets | $9M | $9M | $10M | $11M | $10M | $10M | $10M | $10M | $11M | $11M | $9M | $8M | $9M | · | $11M | $11M | |
| Total Assets | $242M | $267M | $261M | $270M | $266M | $280M | $285M | $292M | $294M | $318M | $325M | $500M | $494M | · | $543M | $558M | |
| Accounts Payable | $27M | $32M | $29M | $35M | $32M | $33M | $30M | $35M | $31M | $38M | $35M | $38M | $25M | · | $36M | $35M | |
| Accrued Liabilities | $29M | $39M | $32M | $30M | $28M | $36M | $37M | $40M | $34M | $41M | $31M | $29M | $26M | · | $22M | $27M | |
| Current Liabilities | $60M | $75M | $66M | $72M | $68M | $76M | $78M | $89M | $77M | $91M | $86M | $78M | $57M | · | $70M | $74M | |
| Capital Leases | $4M | $4M | $4M | $4M | $2M | $2M | $3M | $3M | $3M | $4M | $2M | $3M | $3M | · | $3M | $3M | |
| Other Non-current Liabilities | $14M | $16M | $17M | $17M | $14M | $17M | $17M | $12M | $16M | $16M | $14M | $3M | $3M | · | $3M | $4M | |
| Total Liabilities | $78M | $96M | $87M | $93M | $87M | $97M | $100M | $105M | $97M | $112M | $106M | $98M | $66M | · | $145M | $150M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $50M | $50M | |
| Common Stock | $388.0K | $387.0K | $387.0K | $386.0K | $386.0K | $385.0K | $385.0K | $384.0K | $386.0K | $385.0K | $385.0K | $383.0K | $383.0K | · | $382.0K | $381.0K | |
| Retained Earnings | $-473M | $-466M | $-455M | $-446M | $-440M | $-429M | $-423M | $-419M | $-408M | $-395M | $-382M | $-194M | $-165M | · | $-189M | $-180M | |
| Treasury Stock | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | · | $6M | $6M | |
| AOCI | $5M | $8M | $3M | $998.0K | $61.0K | $-2M | $-4M | $-4M | $-3M | $-4M | $-3M | $-5M | $-6M | · | $-4M | $-288.0K | |
| Stockholders' Equity | $164M | $171M | $173M | $176M | $179M | $183M | $186M | $187M | $197M | $206M | $219M | $401M | $428M | $378M | $398M | $408M | |
| Liabilities + Equity | $242M | $267M | $261M | $270M | $266M | $280M | $285M | $292M | $294M | $318M | $325M | $500M | $494M | · | $543M | $558M | |
| Shares Outstanding | 42,424,450 | 41,700,419 | 41,682,097 | 41,574,212 | 41,446,782 | 40,994,030 | 40,970,831 | 40,835,709 | 41,004,249 | 40,801,597 | 40,424,533 | 40,224,406 | 40,216,641 | 39,981,422 | 39,606,422 | 39,504,144 |
Przepływy pieniężne
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $5M | $6M | $6M | $6M | $6M | $6M | $6M | $7M | $7M | $7M | $8M | $7M | $7M | $8M | $8M | $8M | |
| Stock-based Comp | $5M | $4M | $3M | $3M | $4M | $2M | $2M | $3M | $3M | $2M | $3M | $2M | $4M | $3M | $2M | $3M | |
| Deferred Tax | $-306.0K | $150.0K | $57.0K | $-48.0K | $-16.0K | $-193.0K | $-207.0K | $-249.0K | $-339.0K | $-825.0K | $-12M | $16M | $-11M | $-559.0K | $-227.0K | $-618.0K | |
| Amort. of Intangibles | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $5M | |
| Restructuring | $617.0K | $3M | $5M | $2M | $2M | $2M | $3M | $5M | $4M | $9M | $5M | · | · | · | · | · | |
| Operating Cash Flow | $-15M | $17M | $-3M | $5M | $-16M | $19M | $-13M | $2M | $-18M | $5M | $-13M | $5M | $-26M | $16M | $1M | $7M | |
| CapEx | $379.0K | $413.0K | $1M | $422.0K | $731.0K | $777.0K | $2M | $797.0K | $1M | $566.0K | $607.0K | $554.0K | $791.0K | $1M | $666.0K | $1M | |
| Investing Cash Flow | $-3M | $-1M | $-2M | $-2M | $-2M | $-3M | $-3M | $-2M | $-2M | $-2M | $29M | $-2M | $98M | $-2M | $-2M | $-2M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | · | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | $0 | · | · | · | $-50M | · | · | · | |
| Stock Repurchased | · | $0 | $0 | $0 | $0 | $0 | $0 | $1M | $552.0K | $0 | $0 | $0 | $0 | · | · | · | |
| Net Stock Activity | · | · | · | · | $0 | · | · | · | $-552.0K | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-1M | $-108.0K | $621.0K | $-92.0K | $143.0K | $-6M | $7M | $-1M | $-509.0K | $-5M | $694.0K | $-352.0K | $-60M | $0 | $941.0K | $103.0K | |
| Net Change in Cash | $-20M | $16M | $-4M | $3M | $-17M | $11M | $-9M | $-916.0K | $-21M | $-2M | $18M | $3M | $13M | $15M | $254.0K | $5M | |
| Free Cash Flow | $-16M | · | · | · | $-17M | · | · | · | $-19M | · | · | · | $-27M | · | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | · | $-27M | · | · | · |
Rentowność
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 59.4% | · | 52.9% | 56.4% | 55.3% | · | 54.0% | 54.8% | 54.4% | · | 47.7% | 50.9% | 50.9% | · | 50.2% | 52.8% | |
| Operating Margin | -9.0% | · | -16.5% | -7.7% | -14.1% | · | -13.9% | -15.2% | -19.4% | · | -265.9% | -16.6% | 44.5% | · | -11.1% | -9.5% | |
| Net Margin | -8.8% | · | -10.3% | -8.0% | -14.4% | · | -6.1% | -14.7% | -19.0% | · | -249.7% | -36.7% | 58.3% | · | -11.8% | -9.9% | |
| Pretax Margin | -9.0% | · | -10.3% | -8.0% | -14.3% | · | -6.1% | -14.9% | -18.8% | · | -265.7% | -16.0% | 44.3% | · | -12.0% | -10.6% | |
| EBITDA Margin | -9.0% | · | -16.5% | -7.7% | -14.1% | · | -13.9% | -15.2% | -19.4% | · | -265.9% | -16.6% | 44.5% | · | -11.1% | -9.5% | |
| ROA | -2.8% | · | -3.0% | -2.3% | -3.9% | · | -1.4% | -2.7% | -3.2% | · | -43.3% | -5.5% | 8.7% | · | -1.8% | -1.5% | |
| ROE | -4.1% | · | -4.5% | -3.5% | -5.8% | · | -2.2% | -3.6% | -4.1% | · | -60.9% | -7.2% | 10.9% | · | -2.3% | -2.0% | |
| ROIC | -4.3% | · | -7.5% | -3.5% | -6.0% | · | -5.4% | -5.9% | -6.7% | · | -85.9% | -7.5% | 10.8% | · | -2.2% | -1.9% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | · | 2.4 | 2.2 | 2.3 | · | 2.2 | 2.0 | 2.3 | · | 2.3 | 2.4 | 3.1 | · | 2.2 | 2.2 | |
| Quick Ratio | 1.3 | · | 1.3 | 1.2 | 1.2 | · | 1.1 | 1.1 | 1.2 | · | 1.5 | 1.4 | 1.9 | · | 1.2 | 1.1 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | 507.4 | 24.6 | -294.4 | · | -12.1 | -11.9 |
Efektywność
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.2 | |
| Inventory Turnover | 0.6 | · | 0.6 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | 0.7 | |
| Receivables Turnover | 1.8 | · | 1.8 | 1.8 | 1.8 | · | 1.5 | 1.5 | 1.5 | · | 1.5 | 1.5 | 1.5 | · | 1.7 | 1.9 |
Na akcję
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.86 | · | $4.16 | $4.24 | $4.32 | · | $4.54 | $4.57 | $4.79 | · | $5.41 | $9.97 | $10.64 | · | $10.04 | $10.33 | |
| Revenue / Share | $1.93 | · | $1.89 | $1.91 | $1.84 | · | $1.76 | $1.78 | $1.66 | · | $1.87 | $1.97 | $1.97 | · | $2.04 | $2.16 | |
| Cash Flow / Share | $-0.36 | · | · | · | $-0.39 | · | · | · | $-0.45 | · | · | · | $-0.65 | · | · | · | |
| Cash / Share | $0.80 | · | $0.91 | $1.00 | $0.94 | · | $1.09 | $1.32 | $1.34 | · | $1.94 | $1.51 | $1.43 | · | $0.76 | $0.76 | |
| EPS (TTM) | $-0.79 | · | $-0.75 | $-0.67 | $-0.78 | · | $-1.03 | $-5.59 | $-6.05 | · | $-4.79 | $-0.36 | $0.15 | · | $-0.94 | $-0.83 |
Wycena (TTM)
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $325M | · | $314M | $307M | $301M | · | $283M | $286M | $293M | · | $324M | $330M | $336M | · | $335M | $328M | |
| Net Income TTM | $-33M | · | $-31M | $-28M | $-32M | · | $-41M | $-225M | $-243M | · | $-192M | $-14M | $6M | · | $-37M | $-33M | |
| Market Cap | $684M | · | $477M | $516M | $425M | · | $381M | $283M | $306M | · | $222M | $263M | $323M | · | $490M | $512M | |
| P/E | -20.4 | · | -15.3 | -18.5 | -13.2 | · | -9.0 | -1.2 | -1.2 | · | -1.1 | -18.1 | 53.5 | · | -13.2 | -15.6 | |
| P/S | 2.1 | · | 1.5 | 1.7 | 1.4 | · | 1.3 | 1.0 | 1.0 | · | 0.7 | 0.8 | 1.0 | · | 1.5 | 1.6 | |
| P/B | 4.2 | · | 2.8 | 2.9 | 2.4 | · | 2.0 | 1.5 | 1.6 | · | 1.0 | 0.7 | 0.8 | · | 1.2 | 1.3 | |
| P / Tangible Book | 6.7 | · | 4.4 | 4.7 | 3.8 | · | 3.3 | 2.5 | 2.5 | · | 1.6 | 1.9 | 2.0 | · | 7.7 | 7.8 | |
| P / Cash Flow | -44.6 | · | · | · | -26.7 | · | · | · | -16.8 | · | · | · | -12.5 | · | · | · | |
| Earnings Yield | -4.9% | · | -6.6% | -5.4% | -7.6% | · | -11.1% | -80.7% | -81.1% | · | -87.2% | -5.5% | 1.9% | · | -7.6% | -6.4% |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2026-05-31 | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 |
|---|---|---|---|---|---|
| Przychody | $320M | $292M | $304M | $339M | $316M |
| Marża Brutto % | · | 53.9% | 50.9% | 51.4% | 52.4% |
| Marża Operacyjna % | · | -13.7% | -63.3% | -15.1% | -9.0% |
| Zysk netto | $-37M | $-34M | $-184M | $-52M | $-27M |
| Rozwodniony EPS | $-0.88 | $-0.83 | $-4.59 | $-1.33 | $-0.68 |
| Wskaźnik | 2026-05-31 | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 |
|---|---|---|---|---|---|
| Wskaźnik bieżący | · | 2.2 | 2.1 | 2.0 | 1.9 |
| Wskaźnik Szybkości | · | 1.3 | 1.3 | 1.2 | 1.1 |
| Wskaźnik | 2026-05-31 | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | · | $-15M | $-31M | $-4M | $-11M |
Właściciele instytucjonalni (13F) 174 emitenci · $548.6M łącznie · Na dzień 30 września 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Posiadacze
174
Wartość posiadanych akcji
$548.6M
Nowe pozycje
32
Zamknięte pozycje
15
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 32 (+11 vs poprzedni kw.) | 15 (-17 vs poprzedni kw.) | 54 (-2 vs poprzedni kw.) | 54 (-1 vs poprzedni kw.) | -445K |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $49 480 048 | 3 803 232 | 9,02% | Akcje |
| Point72 Asset Management, L.P. | $39 843 346 | 3 062 517 | 7,26% | Akcje |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | $34 349 199 | 2 640 214 | 6,26% | Akcje |
| VANGUARD GROUP INC | $31 288 936 | 2 436 833 | 5,70% | Akcje |
| ARMISTICE CAPITAL, LLC | $28 595 980 | 2 198 000 | 5,21% | Akcje |
| ROYCE & ASSOCIATES LP | $25 627 553 | 1 969 835 | 4,67% | Akcje |
| Broadfin Holdings LLC | $23 659 114 | 1 818 533 | 4,31% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $22 048 255 | 1 694 716 | 4,02% | Akcje |
| KOTLER KEVIN | $21 997 218 | 1 713 789 | 4,01% | Akcje |
| WEBER CAPITAL MANAGEMENT LLC /ADV | $20 761 493 | 1 349 902 | 3,78% | Akcje |
| Nuveen, LLC | $15 603 649 | 1 199 358 | 2,84% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $13 282 661 | 1 020 658 | 2,42% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $12 613 870 | 969 497 | 2,30% | Akcje |
| STATE STREET CORP | $12 465 753 | 958 167 | 2,27% | Akcje |
| SEGALL BRYANT & HAMILL, LLC | $12 056 510 | 926 711 | 2,20% | Akcje |
| Bastion Asset Management Inc. | $10 782 584 | 923 270 | 1,97% | Akcje |
| Pier Capital, LLC | $10 494 881 | 806 678 | 1,91% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $10 188 456 | 783 125 | 1,86% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $9 547 818 | 733 883 | 1,74% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $9 009 867 | 692 534 | 1,64% | Akcje |
| PARADIGM CAPITAL MANAGEMENT INC/NY | $8 732 312 | 671 200 | 1,59% | Akcje |
| AQR CAPITAL MANAGEMENT LLC | $7 664 932 | 589 157 | 1,40% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $5 735 380 | 440 844 | 1,05% | Akcje |
| MARSHALL WACE, LLP | $5 469 118 | 420 378 | 1,00% | Akcje |
| Western Standard LLC | $5 037 316 | 387 188 | 0,92% | Akcje |
| GOLDMAN SACHS GROUP INC | $4 981 750 | 382 917 | 0,91% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4 866 117 | 374 029 | 0,89% | Akcje |
| BANK OF AMERICA CORP /DE/ | $4 490 310 | 345 143 | 0,82% | Akcje |
| NORTHERN TRUST CORP | $4 289 749 | 329 727 | 0,78% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $3 984 443 | 306 260 | 0,73% | Akcje |
| Phocas Financial Corp. | $3 805 555 | 292 510 | 0,69% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $3 602 664 | 276 915 | 0,66% | Akcje |
| Manatuck Hill Partners, LLC | $3 597 265 | 276 500 | 0,66% | Akcje |
| First Eagle Investment Management, LLC | $3 596 419 | 276 435 | 0,66% | Akcje |
| PANAGORA ASSET MANAGEMENT INC | $3 363 983 | 258 569 | 0,61% | Akcje |
| MORGAN STANLEY | $3 360 665 | 258 314 | 0,61% | Akcje |
| TWO SIGMA ADVISERS, LP | $2 953 213 | 230 001 | 0,54% | Akcje |
| JPMORGAN CHASE & CO | $2 914 230 | 220 775 | 0,53% | Akcje |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $2 852 104 | 219 224 | 0,52% | Akcje |
| KENNEDY CAPITAL MANAGEMENT LLC | $2 509 967 | 192 926 | 0,46% | Akcje |
| Orion Porfolio Solutions, LLC | $2 417 826 | 185 844 | 0,44% | Akcje |
| MOORE CAPITAL MANAGEMENT, LP | $2 382 118 | 183 099 | 0,43% | Akcje |
| LAZARD ASSET MANAGEMENT LLC | $2 008 471 | 154 379 | 0,37% | Akcje |
| Y-Intercept (Hong Kong) Ltd | $1 916 286 | 124 596 | 0,35% | Akcje |
| WHITE PINE CAPITAL LLC | $1 879 477 | 144 464 | 0,34% | Akcje |
| Bank of New York Mellon Corp | $1 619 089 | 124 450 | 0,30% | Akcje |
| Connor, Clark & Lunn Investment Management Ltd. | $1 577 762 | 121 273 | 0,29% | Akcje |
| SEI INVESTMENTS CO | $1 525 673 | 117 269 | 0,28% | Akcje |
| FMR LLC | $1 359 754 | 104 516 | 0,25% | Akcje |
| GLOBEFLEX CAPITAL L P | $1 355 057 | 104 155 | 0,25% | Akcje |
Aktywiści i właściciele 5%+ 7 akcji
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Avista Capital Partners GP, LLC (2), Avista Capital Partners, L.P. (2), Avista Capital Partners (Offshore), L.P. (2), Navilyst Medical Co-Invest, LLC (2) ×5 zgłoszenia | 28 kwietnia 2017 | · | Pierwotne zgłoszenie | · | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 23 grudnia 2008 | · | Pierwotne zgłoszenie | · | SEC |
| Estate of Howard S. Stern., Linda B. Stern. ×4 zgłoszenia | 28 czerwca 2007 | · | Pierwotne zgłoszenie | · | SEC |
| Niezgłoszona osoba raportująca | 16 maja 2005 | · | Pierwotne zgłoszenie | · | SEC |
| Niezgłoszona osoba raportująca | 14 lutego 2005 | · | Pierwotne zgłoszenie | · | SEC |
| Niezgłoszona osoba raportująca | 12 listopada 2004 | · | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
| Niezgłoszona osoba raportująca | 21 października 2004 | · | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insiderzy spółki 58 insiderów · 27 dyrektorzy generalni · 17 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| James C Clemmer | President and CEO | 22 lipca 2026 M | 862 448 | 0 | 0 | $0 |
| Joseph Devivo | President and CEO | 8 września 2015 F | 198 451 | 0 | 0 | $0 |
| Scott J. Solano | Interim CEO | 3 sierpnia 2011 A | 8 945 | 0 | 0 | $0 |
| Jan Keltjens | President & CEO | 19 stycznia 2011 F | 109 276 | 0 | 0 | $0 |
| Stephen A Trowbridge | EVP and CFO | 22 lipca 2026 M | 305 796 | 0 | 0 | $0 |
| Michael Greiner | EVP and CFO | 16 października 2019 A | 33 438 | 0 | 0 | $0 |
| Mark T Frost | EVP and CFO | 6 sierpnia 2015 F | 38 389 | 0 | 0 | $0 |
| Joseph D Gersuk | EVP - CFO | 4 września 2012 F | 47 275 | 0 | 0 | $0 |
| George W. Bourne IV | CTO and COO | 6 sierpnia 2014 F | 23 613 | 0 | 0 | $0 |
| Warren Nighan JR | SVP Quality and Regulatory | 30 lipca 2026 S | 64 745 | 0 | 1 | $-344 006 |
| Laura Piccinini | SVP International | 22 lipca 2026 M | 81 929 | 0 | 0 | $0 |
| Chad Thomas Campbell | SVP/GM, Vascular Access | 22 lipca 2026 M | 108 676 | 0 | 0 | $0 |
| Lawrence T Weiss | SVP, Chief Legal Officer | 15 lipca 2026 A | 112 618 | 0 | 0 | $0 |
| Scott Centea | SVP/GM, VIT | 19 lipca 2023 M | 62 951 | 0 | 0 | $0 |
| Dave Helsel | SVP Global Operations and R&D | 19 lipca 2023 M | 34 462 | 0 | 0 | $0 |
| Richard C Rosenzweig | SVP and General Counsel | 1 lutego 2023 F | 15 730 | 0 | 0 | $0 |
| Brent J. Boucher | SVP and GM of Oncology | 12 lutego 2020 F | 15 416 | 0 | 0 | $0 |
| Robert Arthur Simpson | SVP/GM, Global Vascular | 12 lipca 2019 M | 25 883 | 0 | 0 | $0 |
| Stark Richard | SVP, GM - Oncology | 15 listopada 2017 M | 20 754 | 0 | 0 | $0 |
| Charles R Greiner | VP - Global Franchise | 6 maja 2016 S | 20 910 | 0 | 0 | $0 |
| John Soto | SVP and CCO | 10 września 2015 F | 22 452 | 0 | 0 | $0 |
| Matthew C Kapusta | SVP, Business Development | 17 listopada 2014 F | 30 062 | 0 | 0 | $0 |
| Stephen Mcgill | SVP, GM - International | 28 stycznia 2014 F | 20 715 | 0 | 0 | $0 |
| Richard Scott Etlinger | SVP - Global Operations | 17 sierpnia 2012 A | 11 957 | 0 | 0 | $0 |
| Alan Panzer | SVP, GM - Vascular | 17 sierpnia 2012 A | 27 500 | 0 | 0 | $0 |
| Shawn P Mccarthy | SVP - General Manager | 17 sierpnia 2010 F | 10 392 | 0 | 0 | $0 |
| Lynda M. Wallace | SVP - Business Development | 17 maja 2010 A | · | 0 | 0 | $0 |
| Lorinda Burgess | Dyrektor | 15 lipca 2026 A | 67 144 | 0 | 0 | $0 |
| Karen A Licitra | Dyrektor | 15 lipca 2026 A | 102 322 | 0 | 0 | $0 |
| Michael E Tarnoff | Dyrektor | 15 lipca 2026 A | 95 265 | 0 | 0 | $0 |
| Eileen O'Shea Auen | Dyrektor | 15 lipca 2026 A | 116 605 | 0 | 0 | $0 |
| Wesley Johnson | Dyrektor | 15 lipca 2026 A | 155 425 | 0 | 0 | $0 |
| Howard W Donnelly | Dyrektor | 15 lipca 2026 A | 178 938 | 0 | 0 | $0 |
| Jan Stern Reed | Dyrektor | 15 lipca 2026 A | 116 921 | 0 | 0 | $0 |
| Dennis S Meteny | Dyrektor | 19 lipca 2023 A | 140 019 | 0 | 0 | $0 |
| Kevin J Gould | Dyrektor | 14 lipca 2020 A | 77 504 | 0 | 0 | $0 |
| Jeffrey Gold | Dyrektor | 17 lipca 2019 A | 83 640 | 0 | 0 | $0 |
| Steve Laporte | Dyrektor | 18 lipca 2018 A | 48 484 | 0 | 0 | $0 |
| David F Burgstahler | Dyrektor | 12 kwietnia 2017 S | 381 406 | 0 | 0 | $0 |
| Vincent Bucci | Dyrektor | 23 października 2013 A | 88 312 | 0 | 0 | $0 |
| Charles Thomas Orsatti | Dyrektor | 3 sierpnia 2011 A | 2 000 | 0 | 0 | $0 |
| Paul S Echenberg | · | 23 kwietnia 2012 M | 154 412 | 0 | 0 | $0 |
| Harold Mapes | · | 7 września 2010 M | 14 934 | 0 | 0 | $0 |
| William M Appling | · | 7 września 2010 M | 16 636 | 0 | 0 | $0 |
| Robert M Rossell | · | 8 października 2009 A | 8 945 | 0 | 0 | $0 |
| Eamonn P Hobbs | · | 13 lutego 2009 S | 100 401 | 0 | 0 | $0 |
| Robert E Flaherty | · | 6 sierpnia 2008 A | 3 700 | 0 | 0 | $0 |
| Robert D Mitchell | · | 17 sierpnia 2007 A | 1 242 | 0 | 0 | $0 |
| Daniel Recinella | · | 17 sierpnia 2007 A | 1 196 | 0 | 0 | $0 |
| Brian Kunst | · | 17 sierpnia 2007 A | 1 500 | 0 | 0 | $0 |
| Joseph G Gerardi | · | 17 sierpnia 2007 A | 5 052 | 0 | 0 | $0 |
| Paul J Shea | · | 9 sierpnia 2007 M | 2 562 | 0 | 0 | $0 |
| Linda B Stern | · | 20 grudnia 2006 M | 0 | 0 | 0 | $0 |
| Peter J Graham | · | 25 października 2006 M | 27 778 | 0 | 0 | $0 |
| Gregory D Casciaro | · | 15 sierpnia 2006 A | 500 | 0 | 0 | $0 |
| David P Meyers | · | 15 sierpnia 2006 A | 356 980 | 0 | 0 | $0 |
| Howard S Stern | · | 28 grudnia 2005 S | 1 647 687 | 0 | 0 | $0 |
| EZ EM INC | · | 11 października 2004 J | 0 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 30 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,42% | 7 155 SH | 28 października 2026 | Dziennie |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,31% | 99 622 SH | 28 października 2026 | Dziennie |
| IWC · iShares Trust | 0,13% | 126 421 SH | 11 września 2026 | Dziennie |
| IHI · iShares Trust | 0,09% | 197 283 SH | 11 września 2026 | Dziennie |
| GSSC · Goldman Sachs ETF Trust | 0,09% | 60 953 NS | 31 sierpnia 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,09% | 50 141 SH | 19 sierpnia 2026 | Dziennie |
| VFQY · VANGUARD WELLINGTON FUND | 0,03% | 9 180 SH | 19 sierpnia 2026 | Dziennie |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 61 129 SH | 28 października 2026 | Dziennie |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 24 898 SH | 19 sierpnia 2026 | Dziennie |
| IWM · iShares Trust | 0,02% | 955 368 SH | 11 września 2026 | Dziennie |
| RSSL · Global X Funds | 0,02% | 17 796 NS | 31 lipca 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 200 018 NS | 31 sierpnia 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,01% | 137 468 NS | 31 lipca 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 484 612 SH | 19 sierpnia 2026 | Dziennie |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 214 186 SH | 19 sierpnia 2026 | Dziennie |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 9 350 SH | 19 sierpnia 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,01% | 108 819 SH | 19 sierpnia 2026 | Dziennie |
| IWO · iShares Trust | 0,01% | 83 883 SH | 11 września 2026 | Dziennie |
| DXUV · Dimensional ETF Trust | 0,01% | 1 917 NS | 31 lipca 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 110 473 NS | 31 lipca 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 5 298 NS | 31 lipca 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 3 043 NS | 31 lipca 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 83 876 SH | 11 września 2026 | Dziennie |
| DFAU · Dimensional ETF Trust | 0,00% | 10 769 NS | 31 lipca 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 10 501 SH | 3 września 2026 | Dziennie |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 23 038 NS | 31 sierpnia 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 9 874 NS | 31 lipca 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 173 227 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2 942 SH | 19 sierpnia 2026 | Dziennie |
| IWN · iShares Trust | · | 259 544 SH | 11 września 2026 | Dziennie |
ANGO Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
ocena · 10 analityków
KUP
Średni cel
$19.00
+56,6%
2 20,0%
Mocne kupno
7 70,0%
Kup
1 10,0%
Trzymaj
0 0,0%
Sprzedaj
0 0,0%
Mocna sprzedaż
12-miesięczny cel cenowy
4 analityków · 2026-10-29Średnia cel $19.75 +62,8%
← Poniżej wszystkich celów
Aktualna cena $12.13
Niski$17.00
Średnia$19.75
Wysoki$24.00
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| ANGO | · | -13.0 | 9.5% | · | · | · |
| VREX | $498M | -7.0 | 4.1% | -8.3% | -14.0% | 34.4% |
| AVR | $207M | -2.0 | -29.2% | -4921.3% | -300.5% | · |
| TCMD | $651M | 35.4 | 12.5% | 5.8% | 9.2% | 75.9% |
| DCTH | $350M | 144.3 | 129.1% | 3.2% | 2.5% | 86.2% |
| SGHT | $424M | -10.7 | -3.1% | -49.7% | -57.4% | 86.2% |
| SSII | · | -94.7 | 105.7% | · | · | · |
| SENS | $228M | -3.3 | 56.9% | -196.0% | -88.7% | 44.7% |
| NPCE | $518M | -23.4 | 25.1% | -21.5% | -111.6% | 77.2% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Źródło: SEC 10-Q złożone Paź 8, 2026